GLP-1 agonist medications have gained significant ... prescribed for diabetes management or weight loss. Here is a list of commonly prescribed GLP-1 medications: GLP-1 medications offer a range ...

Last week, Vermont Senator Bernie Sanders pressed the chief executive officer of Novo Nordisk to lower prices of popular weight-loss drugs such as semaglutide – marketed in the United States as ...

Wegovy was the first to market from a newer generation of medicines known as GLP-1 agonists, originally developed for diabetes, that provide a new way to address record obesity rates. Eli Lilly ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Continuing GLP-1 receptor agonist medications when undergoing an endoscopic procedure appeared safe in a meta-analysis.

While the drugs remain on the shortage list for now, they are no longer listed as “currently in shortage” by the FDA. Both ...

Potentially adding to a lengthening list of positive health benefits of GLP-1 agonist drugs, a new study has suggested they may also reduce the risk of a bevy of cancers associated with being very ...

Recent studies have shown that pharmacological treatment with GLP-1-RA and dual GLP-1/glucose-dependent insulinotropic ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

It's possible that Alzheimer's disease could be added to the lengthening list of health conditions that can be improved by treatment with GLP-1 receptor agonists. The phase 2 ELAD study of Novo ...

Opens in a new tab or window PHILADELPHIA -- Chest x-rays did not support the existence of an aspiration risk for surgical candidates using GLP-1 receptor agonists, according to a retrospective study.

Only 13 states currently allow Medicaid to cover GLP-1 agonist drugs for obesity treatment, highlighting a significant gap in ...